Barclays’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,000
| Closed | -$163K | – | 5593 |
|
|
2021
Q4 | $163K | Hold |
2,000
| – | – | ﹤0.01% | 3623 |
|
|
2021
Q3 | $133K | Hold |
2,000
| – | – | ﹤0.01% | 3790 |
|
|
2021
Q2 | $134K | Hold |
2,000
| – | – | ﹤0.01% | 3729 |
|
|
2021
Q1 | $104K | Sell |
2,000
-72,400
| -97% | -$3.66M | ﹤0.01% | 3992 |
|
|
2020
Q4 | $2.97M | Hold |
74,400
| – | – | ﹤0.01% | 1934 |
|
|
2020
Q3 | $1.82M | Hold |
74,400
| – | – | ﹤0.01% | 2189 |
|
|
2020
Q2 | $1.35M | Sell |
74,400
-15,000
| -17% | -$296K | ﹤0.01% | 2487 |
|
|
2020
Q1 | $1.29M | Sell |
89,400
-27,400
| -23% | -$787K | ﹤0.01% | 2705 |
|
|
2019
Q4 | $4.44M | Sell |
116,800
-5,200
| -4% | -$156K | ﹤0.01% | 2134 |
|
|
2019
Q3 | $2.7M | Sell |
122,000
-58,600
| -32% | -$1.25M | ﹤0.01% | 2501 |
|
|
2019
Q2 | $3.73M | Buy |
180,600
+22,200
| +14% | +$512K | ﹤0.01% | 2156 |
|
|
2019
Q1 | $4.57M | Buy |
158,400
+24,600
| +18% | +$607K | ﹤0.01% | 1730 |
|
|
2018
Q4 | $2.29M | Buy |
133,800
+102,000
| +321% | +$2.47M | ﹤0.01% | 2272 |
|
|
2018
Q3 | $905K | Buy |
31,800
+6,100
| +24% | +$201K | ﹤0.01% | 3722 |
|
|
2018
Q2 | $863K | Sell |
25,700
-15,200
| -37% | -$473K | ﹤0.01% | 3448 |
|
|
2018
Q1 | $992K | Sell |
40,900
-74,300
| -64% | -$1.48M | ﹤0.01% | 3226 |
|
|
2017
Q4 | $1.75M | Sell |
115,200
-92,300
| -44% | -$1.3M | ﹤0.01% | 2560 |
|
|
2017
Q3 | $3.41M | Buy |
207,500
+111,200
| +115% | +$1.89M | ﹤0.01% | 1839 |
|
|
2017
Q2 | $1.86M | Buy |
96,300
+68,300
| +244% | +$1.19M | ﹤0.01% | 2324 |
|
|
2017
Q1 | $496K | Sell |
28,000
-6,800
| -20% | -$126K | ﹤0.01% | 3410 |
|
|
2016
Q4 | $516K | Buy |
34,800
+18,700
| +116% | +$335K | ﹤0.01% | 3342 |
|
|
2016
Q3 | $365K | Sell |
16,100
-40,800
| -72% | -$1.06M | ﹤0.01% | 3492 |
|
|
2016
Q2 | $1.57M | Buy |
56,900
+11,000
| +24% | +$325K | ﹤0.01% | 2213 |
|
|
2016
Q1 | $1.28M | Sell |
45,900
-30,300
| -40% | -$788K | ﹤0.01% | 2324 |
|
|
2015
Q4 | $2.29M | Buy |
76,200
+17,200
| +29% | +$564K | ﹤0.01% | 1920 |
|
|
2015
Q3 | $2.12M | Sell |
59,000
-220,500
| -79% | -$11.4M | ﹤0.01% | 2066 |
|
|
2015
Q2 | $15.9M | Buy |
279,500
+185,800
| +198% | +$9.49M | 0.02% | 778 |
|
|
2015
Q1 | $4.59M | Sell |
93,700
-26,900
| -22% | -$1.26M | 0.01% | 1632 |
|
|
2014
Q4 | $6.03M | Buy |
120,600
+37,600
| +45% | +$1.97M | 0.01% | 1543 |
|
|
2014
Q3 | $4.9M | Buy |
83,000
+44,900
| +118% | +$2.51M | ﹤0.01% | 1794 |
|
|
2014
Q2 | $1.75M | Sell |
38,100
-16,300
| -30% | -$737K | ﹤0.01% | 2747 |
|
|
2014
Q1 | $2.29M | Buy |
54,400
+5,800
| +12% | +$256K | ﹤0.01% | 2419 |
|
|
2013
Q4 | $2.04M | Buy |
48,600
+12,400
| +34% | +$540K | ﹤0.01% | 2645 |
|
|
2013
Q3 | $1.48M | Buy |
36,200
+17,300
| +92% | +$724K | ﹤0.01% | 2915 |
|
|
2013
Q2 | $871K | Buy |
+18,900
| New | +$846K | ﹤0.01% | 3561 |
|
Other funds holding THC
VPM
VCM
LPC
Barclays's THC Position: Q1 2026 in Review
Barclays reduced its Tenet Healthcare (THC) stake by 32% in Q1 2026, selling an estimated $6.28M and leaving 64,342 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1348.
Barclays first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $83M in Q2 2022. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Barclays held 64,342 shares of Tenet Healthcare worth $12.1M as of Q1 2026.
- Barclays sold 29,817 Tenet Healthcare shares in Q1 2026, an estimated $6.28M.
- Tenet Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1348 holding.
- Barclays first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
- Barclays's Tenet Healthcare position peaked at $83M in Q2 2022.
- 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.